Point72 Hong Kong LTD Ovid Therapeutics Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $10,877 - $32,633	-4,771 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.39 - $8.24 $23,969 - $36,643	4,447 Added 1372.53%	4,771 $27,000
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $865 - $2,562	324 New	324 $2,000
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $174 - $374	-86 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $178 - $435	86 New	86 $0
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $594 - $800	-374 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $661 - $1,331	374 New	374 $1,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $67.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.